비뇨의학 Urology Digest ISSN:2713-7910(Print) 2733-5453(Online)

Kim M et al., Clinical and pathologic characteristics of familial prostate cancer in Asian population, Prostate, 2020

Lambert SA et al., Towards clinical utility of polygenic risk scores, Hum Mol Genet, 2019 10.1093/hmg/ddz18731363735

Black MH et al., Validation of a prostate cancer polygenic risk score, Prostate, 2020 10.1002/pros.2405833258481PMC7590110

Eklund M et al., The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing, Eur Urol Focus, 2018 10.1016/j.euf.2016.10.00928753803

Akamatsu S et al., Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese, PLoS One, 2012 10.1371/journal.pone.004645423071574PMC3468627

Takata R. et al., 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population, Nat Commun, 2019

Song SH et al., Prediction of clinically significant prostate cancer using polygenic risk models in Asians, Investig Clin Urol, 2022 10.4111/icu.2021030534983122PMC8756152

Song SH et al., Polygenic risk score for genetic evaluation of prostate cancer risk in Asian populations: A narrative review, Investig Clin Urol, 2021 10.4111/icu.2021012433943048PMC8100017